Dr. Parker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3855 Health Sciences Dr
Mail Code 0987
La Jolla, CA 92093Phone+1 858-249-3248Fax+1 858-249-3250- Is this information wrong?
Summary
- I am a breast medical oncologist and former senior cancer center administrator with over 30 years of experience in clinical care, clinical and translational research, cancer strategic planning and cancer clinical operations.
Education & Training
- University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1987
- University of California (San Diego) Medical CenterChief Residency, Internal Medicine, 1984 - 1985
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1981 - 1984
- Stanford University School of MedicineClass of 1981
Certifications & Licensure
- CA State Medical License 1982 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Docs San Diego 2006-2020
- Lifetime Achievement Award American Cancer Society San Diego, 2019
- Lifetime Achievement Award UCSD Moores Cancer Center, 2018
- Join now to see all
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Publications & Presentations
PubMed
- Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer.Rebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, Richard B Schwab, Emily I Pittman, Minya Pu, Elizabeth Weihe, Emanuela M Ghia, Laura Z Rassenti, Alfredo Molino...> ;Breast Cancer Research. 2024 Mar 13
- 1 citationsA phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer.Rebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, Richard B Schwab, Emily I Pittman, Minya Pu, Elizabeth Weihe, Emanuela M Ghia, Laura Z Rassenti, Alfredo Molino...> ;Breast Cancer Research. 2024 Feb 26
- 2 citationsGrowth signaling autonomy in circulating tumor cells aids metastatic seeding.Sinha, S., Farfel, A., Luker, K., Luker, G., Ghosh, P., Parker, B., Yeung, K.> ;PNAS Nexus. 2024 Feb 1
- Join now to see all
Press Mentions
- Researchers to Test Novel Drug Combination Against Toughest Breast CancersAugust 27th, 2018
- UCSD Launches New Clinical Trial for Breast Cancer DrugAugust 27th, 2018
Professional Memberships
- Member
- Member
Hospital Affiliations
- UC San Diego Medical Center - HillcrestSan Diego, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: